Abbott Laboratories Statistics

Total Valuation

SNSE:ABT has a market cap or net worth of CLP 200.73 trillion. The enterprise value is 205.86 trillion.

Market Cap	200.73T
Enterprise Value	205.86T

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	1.74B
Shares Outstanding	n/a
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	80.92%
Float	1.73B

Valuation Ratios

The trailing PE ratio is 14.99 and the forward PE ratio is 22.38.

PE Ratio	14.99
Forward PE	22.38
PS Ratio	4.76
PB Ratio	4.07
P/TBV Ratio	9.76
P/FCF Ratio	30.18
P/OCF Ratio	22.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.41, with an EV/FCF ratio of 30.95.

EV / Earnings	15.37
EV / Sales	5.09
EV / EBITDA	18.41
EV / EBIT	25.89
EV / FCF	30.95

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.25.

Current Ratio	1.70
Quick Ratio	1.09
Debt / Equity	0.25
Debt / EBITDA	1.07
Debt / FCF	1.88
Interest Coverage	16.93

Financial Efficiency

Return on equity (ROE) is 30.62% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE)	30.62%
Return on Assets (ROA)	6.79%
Return on Invested Capital (ROIC)	9.03%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	369.82M
Profits Per Employee	117.47M
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.84

Taxes

Income Tax	-5,614.84B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.04%
50-Day Moving Average	133.81
200-Day Moving Average	117.76
Relative Strength Index (RSI)	100.00
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.09

Income Statement

In the last 12 months, SNSE:ABT had revenue of CLP 42.16 trillion and earned 13.39 trillion in profits. Earnings per share was 7,655.16.

Revenue	42.16T
Gross Profit	23.72T
Operating Income	8.29T
Pretax Income	7.83T
Net Income	13.39T
EBITDA	11.30T
EBIT	8.29T
Earnings Per Share (EPS)	7,655.16

Full Income Statement

Balance Sheet

The company has 7.44 trillion in cash and 12.48 trillion in debt, giving a net cash position of -5,040.76 billion.

Cash & Cash Equivalents	7.44T
Total Debt	12.48T
Net Cash	-5,040.76B
Net Cash Per Share	n/a
Equity (Book Value)	49.30T
Book Value Per Share	28,177.97
Working Capital	9.86T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.77 trillion and capital expenditures -2,117.47 billion, giving a free cash flow of 6.65 trillion.

Operating Cash Flow	8.77T
Capital Expenditures	-2,117.47B
Free Cash Flow	6.65T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.26%, with operating and profit margins of 19.65% and 31.88%.

Gross Margin	56.26%
Operating Margin	19.65%
Pretax Margin	18.56%
Profit Margin	31.88%
EBITDA Margin	26.79%
EBIT Margin	19.65%
FCF Margin	15.78%

Dividends & Yields

This stock pays an annual dividend of 2,298.30, which amounts to a dividend yield of 1,717.59%.

Dividend Per Share	2,298.30
Dividend Yield	1,717.59%
Dividend Growth (YoY)	12.34%
Years of Dividend Growth	7
Payout Ratio	28.93%
Buyback Yield	0.04%
Shareholder Yield	1,717.63%
Earnings Yield	6.67%
FCF Yield	3.31%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNSE:ABT has an Altman Z-Score of 5.83 and a Piotroski F-Score of 6.

Altman Z-Score	5.83
Piotroski F-Score	6